Weill Cornell Medicine researchers are using machine learning, a form of artificial intelligence, to shed light on genetic mutations associated with spina bifida. In this birth defect, the neural tube that forms the spinal cord during pregnancy, does not close so that spinal nerves are exposed, resulting in paralysis and high risk of other complications.
Reducing Copper in the Body Reduces Risk of Aggressive Breast Cancer
December 15, 2021
Depleting copper levels may reduce the production of energy that cancer cells need to travel and establish themselves in other parts of the body by a process referred to as metastasis, according to a new study by investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center (MSK). The discovery of the underlying mechanisms of how copper depletion may help reduce metastasis in breast cancer will help inform the design of future clinical trials.
Researchers Identify Significant Differences in Tumors of Younger and Older Patients
December 7, 2021
Investigators at Weill Cornell Medicine have identified significant differences in the molecular characteristics of tumors from younger and older cancer patients across several cancer types.
Protein Variant Identified that Renders Chemotherapy Ineffective
December 6, 2021
A new protein variant underlies the ability of gastric cancers to resist an otherwise effective family of chemotherapy drugs, according to a study by a multidisciplinary team at Weill Cornell Medicine. The results suggest a treatment strategy that could improve the prognoses of many patients with cancer.
December 2021 EIPM Director's Memo
December 2, 2021
Dear Members of the Englander Institute,
It’s always a pleasure to share the important work and contributions of our colleagues, especially those who are just beginning their careers. Over the next month we will feature interviews with several of our team members on the News page of our website (see below). I hope you enjoy learning more about their backgrounds and research interests.
Detecting cancer with a simple blood draw could soon be a reality
November 24, 2021
One experimental test can detect 50 different cancers.
Every year, thousands of Americans undergo routine screening to catch cancer in its early stages, while it’s still treatable. But these routine tests can be painful and invasive, and doctors only regularly screen for five of some of the most common types of cancer.
Diabetes and Atherosclerosis Link
November 10, 2021
Hyperglycemia—excess blood sugar, the central feature of diabetes—can react with immune proteins to cause changes in the immune system, including those that promote atherosclerosis.
While doctors have known for decades that chronic hyperglycemia increases the risk of atherosclerosis and weakens immunity against infections, the new study describes the molecular pathways by which it happens.
A Conversation with Jenna Moyer
November 8, 2021
We are pleased to introduce our colleague Jenna Moyer, a Research Specialist on the EIPM organoid team.
We hope you enjoy learning more about her research interests and background!
Question: Can you please tell me about your work with organoids and how you first learned about this area of research?
EIPM Directors Memo November 2021
October 31, 2021
Dear Members of the Englander Institute,
It’s always a pleasure to share the important work and contributions of our colleagues, especially those who are just beginning their careers. Over the next several weeks we will feature interviews on the News page of our website with colleagues like Helen Kuo, a PhD Candidate mentored by myself and Dr. Laura Martin. I hope you enjoy learning more about their backgrounds and research interests.
EIPM, MCC & MoMA Save Summer for Dozens of Local Students
October 22, 2021
Many young people hoped the summer of 2021 would represent a return to normalcy in New York City. The continuing Covid-19 pandemic and Delta variant, however, upended many of those plans to find meaningful opportunities for personal, social, and educational growth during the summer months.
But not all summer plans were dashed. 48 high school and college students enjoyed a rich and rewarding six-week virtual summer program hosted by Weill Cornell Medicine’s (WCM) Englander Institute for Precision Medicine and the Meyer Cancer Center.